|
|
Name: |
Omega Fund Management (US) Inc. |
City: |
BOSTON |
State: |
MA |
Zip: |
02116 |
|
|
|
Achive
data |
View
Filing Period: |
|
|
|
|
|
|
Download |
|
|
|
|
|
Free Registration Required For Full Results
|
|
|
Holdings
Found :
7 |
|
View All Holdings |
Currently
Viewing:
Unchanged Positions |
|
|
Page 1 of 1 |
Menu
|
Ticker |
Company Name |
Position Rank |
New/Closed Postion |
Last Close |
Value |
Shares Held |
% of Portfolio |
Value Change |
Change In Shares Held |
% of Company |
Industry |
|
LXEO |
Lexeo Therapeutics, Inc. |
2 |
- |
$0.00 |
$37,789,000 |
2,355,904 |
28% |
848,000 |
0 |
0 |
N/A |
|
ENGN |
Engene Holdings Inc. |
4 |
- |
$8.68 |
$10,150,000 |
1,076,357 |
7.52% |
-8,094,000 |
0 |
2.437 |
N/A |
|
MORF |
Morphic Holding, Inc. |
5 |
- |
$56.99 |
$5,446,000 |
159,846 |
4.03% |
-181,000 |
0 |
0.321 |
N/A |
|
SANA |
Sana Biotechnology, Inc. |
6 |
- |
$0.00 |
$4,607,000 |
843,750 |
3.41% |
-3,831,000 |
0 |
0.45 |
N/A |
|
IKNA |
Ikena Oncology, Inc. |
7 |
- |
$0.00 |
$3,711,000 |
2,249,123 |
2.75% |
517,000 |
0 |
4.66 |
N/A |
|
IMUX |
Immunic Inc |
8 |
- |
$1.24 |
$1,985,000 |
1,788,160 |
1.47% |
-375,000 |
0 |
1.985 |
N/A |
|
SYRS |
Syros Pharmaceuticals, Inc. |
9 |
- |
$2.51 |
$1,297,000 |
251,270 |
0.96% |
-47,000 |
0 |
0.447 |
N/A |
|